🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCardiovascular OutcomesNNT for MACE prevention — July 2024 Page 4

NNT for MACE prevention — July 2024

gary_naperville Sat, Sep 21, 2024 at 10:59 AM 36 replies 1,910 viewsPage 4 of 8
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Sep 21, 2024 at 4:39 PM#16

Just wanted to say — for anyone reading this NNT for MACE thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

Last edited: Sep 21, 2024 at 8:39 PM
39 13Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 36 others
Reply Quote Save Share Report
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Sep 21, 2024 at 4:56 PM#17

gary_naperville's experience with NNT for MACE prevention resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I started 3 months later. But the overall trajectory has been remarkably similar. Down 34 lbs in 9 months.

One thing I would add that gary_naperville did not mention: the mental health improvements were just as significant.

38 24wei_SG, cory_ATX, lori_vegas and 35 others
Reply Quote Save Share Report
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Sep 21, 2024 at 5:13 PM#18

Saving this for reference. Top-tier content.

Last edited: Sep 21, 2024 at 11:13 PM
33 18PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 30 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides
paige_pharma
Member
289
1,234
Sep 2024
Omaha, NE
Sep 21, 2024 at 5:30 PM#19

As a pharmacist, I want to add some clinical context to this discussion on NNT for MACE prevention July 2024.

Building on what gary_naperville said — the evidence base here is robust. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Sep 21, 2024 at 6:30 PM
25 18lisa_labSD, adam_van, Dr.SurgeonPGH and 22 others
Reply Quote Save Share Report
SleepFixSam
Member
212
678
Nov 2024
Hawaii
Sep 21, 2024 at 5:47 PM#20

Subscribing to this thread. NNT for MACE prevention is exactly what I've been researching. 🙏

Last edited: Sep 21, 2024 at 7:47 PM
47 0fiona_VT, denise_HTX, raj_cambridge and 44 others
Reply Quote Save Share Report

Similar Threads

SELECT trial: 20% MACE reduction — mechanistic deep dive7 replies
Semaglutide cardiovascular benefit independent of weight loss11 replies
STEP-HFpEF: semaglutide in heart failure with preserved EF15 replies
GLP-1 and arterial inflammation — hsCRP and IL-6 reduction data18 replies
Lp(a) on GLP-1 agonists — any impact on this risk factor?8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register